H. Al Moubaker et al. / Open Journal of Obstetrics and Gynecology 3 (2013) 739-742
Copyright © 2013 SciRes.
742
Neuroen docrine tumors are often growing slowly. Pa-
radoxically, this slow evolution is often responsible for
late diagnosis. Upon detection of neuroendocrine tumor
is often add that the existence of metastases.
OPEN ACCESS
Fortunately, research evolves impressive in the diag-
nosis and management of these tumors. Moreover, their
relatively good prognosis for some of them can hope.
REFERENCES
[1] Capella, C., Heitz, P.U., Höffler, H., Solcia, E. and Klöp-
pel, G. (1995) Revised classification of neuroendocrine
tumours of the lung, pancreas and gut. Virchows Archiv,
425, 547-560. http://dx.doi.org/10.1007/BF00199342
[2] Pearse, A.G.E. (1969) The cytochemistry and ultrastruc-
ture of polypeptide hormone-producing cells of the
APUD series, and the embryologic, physiologic and pa-
thologic implications of the concept. Journal of Histoche-
mistry & Cytochemistry, 17, 303-313.
http://dx.doi.org/10.1177/17.5.303
[3] Le Douarin, N.M., Teillet, M.A. and Couly, G. (1990)
Chimères embryonnaireset développement du système
nerveux. Medecine Sciences, 6, 228-244.
[4] Andrew, A., Kramer, B. and Rawdon, B. (1998) The ori-
gin of gut and pancreatic neuroendocrine (APUD) cells-
the last word? The Journal of Pathology, 186, 117-118.
http://dx.doi.org/10.1002/(SICI)1096-9896(1998100)186:
2<117::AID-PATH152>3.0.CO;2-J
[5] Lechago, J. and Gould, V.E. (1997) Blood worth’s endo-
crine pathology, 3rd Edition, Williams & Wilkins, Balti-
more.
[6] Saint-André, J.P., Valo, I. and Guyétant, S. (2000) Im-
munohistochimie des tumeurs neuro-endocrines. Annales
de Pathologie, 20, S129-31.
[7] Oda, Y., Tanaka, Y., Naruse, T., Sasanabe, R., Tsubamo-
to, M. and Funahashi, H. (2002) Expression of somatos-
tatin receptor and effects of somatostatin analog on pan-
creatic endocrine tumors. Surgery Today, 32, 690-694.
http://dx.doi.org/10.1007/s005950200128
[8] Hauser, H., Wolf, G., Uranus, S. and Klimpfinger, M.
(1995) Neuroendocrine tumours in various organ systems
in a ten-year period. European Journal of Surgical On-
cology, 21, 297-300.
http://dx.doi.org/10.1016/S0748-7983(95)91624-5
[9] Modlin, I.M. and Sandor, A. (1997) An analysis of 8305
cases of carcinoid tumors. Cancer, 79, 813-829.
http://dx.doi.org/10.1002/(SICI)1097-0142(19970215)79:
4<813::AID-CNCR19>3.0.CO;2-2
[10] Williams, E.D. and Sandler, M. (1963) The classification
of carcinoid tumours. Lancet, 281, 238-239.
http://dx.doi.org/10.1016/S0140-6736(63)90951-6
[11] Travis, W.D., Colby, T.V., Corrin, B., et al. (1999) His-
tological typing of lungand pleural tumours. WHO Inter-
national Histological Classificationof Tumours, Springer,
Berlin. http://dx.doi.org/10.1007/978-3-642-60049-4
[12] Solcia, E., Klöppel, G. and Sobin, L.H. (2000) Histologi-
cal typing of endocrine tumours. WHO International His-
tological Classification of Tumours. Springer, Berlin.
http://dx.doi.org/10.1007/978-3-642-59655-1
[13] Capella, C., Sessa, F., Cornaggia, M., La Rosa, S. and
Uccella, S. (1999) Mixedexocrine-endocrine tumors of
the gastro-intestinal tract. Revista española de Patología,
32, 466-467.
[14] Heymann, M.F., Joubert, M., Nemeth, J., Franc, B., Vis-
set, J., Hamy, A., le Borgne, J., le Neel, J.C., Murat, A.,
Cordel, S. and le Bodic, M.F. (2000) Prognostic and im-
munohistochemical validation of the Capella classifica-
tion of pancreatic neuroendocrine tumours: An analysis
of 82 sporadic cases. Histopathology. 36, 421-432.
http://dx.doi.org/10.1046/j.1365-2559.2000.00892.x
[15] Gumbs, A.A., Moore, P.S., Falconi, M. Bassi, C., Be-
ghelli, S., Modlin, I. and Scarpa, A. (2002) Review of the
clinical, histological and molecular aspects of pancreatic
endocrine neoplasms. Journal of Surgical Oncology, 81,
45-53. http://dx.doi.org/10.1002/jso.10142
[16] Le Bodic, M.F., Heymann, M.F., Lecomte, M., Berger,
N., Berger, F., Louvel, A., De Micco, C., Patey, M., De
Mascarel, A., Burtin, F. and Saint-Andre, J.P. (1995) Im-
muno-histochemical study of 100 pancreatic tumors in 28
patients with Multiple Endocrine Neoplasia type 1. The
American Journal of Surgical Pathology, 20, 1378-1384.
http://dx.doi.org/10.1097/00000478-199611000-00009
[17] Komminoth, P. (1999) Review: Multiple endocrine ne-
oplasia type 1, sporadic n eur oendocrine tumors, and MENIN.
Diagnostic Molecular Pathology, 8, 107-112.
http://dx.doi.org/10.1097/00019606-199909000-00001
[18] Matias-Guiu, X. (1998) RET protooncogene analysis in
the diagnosis ofmedullary thyroid carcinoma and muliple
endocrine neoplasiatype II. Advances in Anatomic Patho-
logy, 5, 196-201.
http://dx.doi.org/10.1097/00125480-199805000-00058